how does glp-1 work in the body Glucagon-like peptide-1 GLP-1 | Summary

A 2023 analysis of the SUSTAIN and PIONEER trials published in Cardiovascular Diabetology showed significant reductions in high-sensitivity C-reactive protein, a marker of systemic inflammation, among patients taking semaglutide

The role of glucagon-like peptide 1 (GLP-1) in addictive disorders

Think of it as a three-in-one treatment that combines the appetite control of Ozempic with extra power to help the body burn fat

Weeks 17 and beyond (optimization phase): If weight loss plateaus and you have not reached your goal, further dose increases (up to 15 mg weekly) may be appropriate

64 In the STEP-HFpEF study, the incidence of AF and atrial flutter was lower in the semaglutide group than in the placebo group (1.1% versus 3.4% and 0% versus 1.1%, respectively)